KARACHI: Aziz ul Huq, Chief Executive Officer of GlaxoSmithKline Pakistan Limited has resigned for personal reasons and the board of directors of the company appointed Ms. Erum Shakir Rahim as new CEO of the company from March 01, 2020.
In a notice to Pakistan Stock Exchange (PSX) on Thursday, the company said that Aziz ul Huq, CEO, GlaxoSmithKline Pakistan Limited had resigned to join his family in Australia.
The board of directors has accepted his resignation with effect from March 01, 2020 and extended their best wishes to him in his future endeavors.
“The board of directors has also appointed Ms. Erum Shakir Rahim, General Manager, GSK Indonesia Pharma Emerging Markets as new Chief Executive Officer of GlaxoSmithKline Pakistan Limited with effect from March 01, 2020.”
The company said that Ms. Erum Shakir Rahim had a strong track record of success in multiple GM roles within GSK in Malaysia (Brunei), Bangladesh (Developing Countries Asia cluster) and Indonesia.
In her role as GM Indonesia Erum led the team to transform the business and deliver strong top line growth 12 percent, OP growth of 25 percent, increase in market share, rank and EI of 106. With a high people engagement score of 87 percent.
Before taking on general management roles outside Pakistan, Erum worked as director marketing Sales and Business Development GSK Pakistan, Iran and Afghanistan. Where she did multiple commercial and strategic roles of increasing responsibility across pharma, vaccines and consumers. These included roles in marketing, sales, comms, GA and business development.
She contributed to GSK Pakistan’s market leading position in the country with 12 percent market share and eight GSK brands in the top 20 by launching 20 new assets across several therapy areas as well as leading critical business development initiatives. She is also on the board of directors in GSK Pakistan and Bangladesh in her previous roles.
